Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activating transcription factor 1 pseudogene 1 (ATF1P1) is a non-functional DNA sequence in the human genome that resembles the protein-coding gene ATF1 but does not produce a protein product[8][11]. Pseudogenes arise from evolutionary duplication or degradation of functional genes and lack protein-coding capacity due to mutations or interruptions in their sequence. ATF1P1 has no known physiological or disease-related roles, and is not considered a molecular target or biomarker in research or therapy[8][11]. The true functional target, Activating transcription factor 1 (ATF1), is a member of the bZIP family of transcription factors involved in regulating gene expression, growth, and cell survival, and is implicated in certain cancers[4][7]; however, ATF1P1 itself is not therapeutically relevant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activating transcription factor 1 pseudogene 1 (ATF1P1).